Page last updated: 2024-09-05

phosphatidylcholines and Sarcoma, Kaposi

phosphatidylcholines has been researched along with Sarcoma, Kaposi in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azarnia, N; Barrueco, JR; Cheung, TW; Dezube, BJ; Proper, JA; Remick, SC1

Trials

1 trial(s) available for phosphatidylcholines and Sarcoma, Kaposi

ArticleYear
AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Agents; CD4 Lymphocyte Count; Cholesterol; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Humans; Liposomes; Male; Middle Aged; Phosphatidylcholines; Sarcoma, Kaposi; Skin Neoplasms; Time Factors

1999